Mike

Bitcoin

Genius

Read

Cancer-focused biotech Anixa Biosciences announced plans to invest in Bitcoin to strengthen its financial strategy and enhance shareholder value.
The San Jose-based biotech firm stated in a Nov. 22 <a href="https://ir.anixa.com/press-releases/detail/1060/anixa-biosciences-board-of-directors-approves-purchase-of" target="_blank" rel="noopener noreferrer nofollow">press release</a> that it will allocate a portion of its treasury to Bitcoin (<a href="https://crypto.news/price/bitcoin/" target="_blank" rel="noopener noreferrer nofollow">BTC</a>), citing the asset’s “unique inflation-resistant qualities.”
In a Nov. 22 <a href="https://ir.anixa.com/press-releases/detail/1060/anixa-biosciences-board-of-directors-approves-purchase-of" target="_blank" rel="noopener noreferrer nofollow">press release</a>, Anixa said the move has been approved by its board as part of a broader strategy to diversify its cash holdings. The biotech firm emphasized its “strong balance sheet and excess cash,” which allows it to pursue strategic financial initiatives, including diversifying treasury holdings with Bitcoin while maintaining its focus on advancing clinical trials and shareholder returns.
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">
 “With Bitcoin’s growing recognition as a mainstream asset class, we believe it represents a valuable addition to our treasury reserve strategy. The approval of Bitcoin ETFs and increasing participation from institutional investors highlight its rising importance in global markets.”
 Mike Catelani, president and CFO of Anixa
</blockquote>
Anixa’s chief executive Amit Kumar highlighted the firm’s disciplined approach to financial management, stating that the Bitcoin allocation is an “additional approach to prudent financial management, enabling greater shareholder value.” Following the announcement, Anixa shares soared 7.84% in pre-market trading.
You might also like: <a rel="noopener noreferrer nofollow" href="https://crypto.news/bitcoin-mirrors-2020-bull-phase-cryptoquant-ceo-says/"> Bitcoin mirrors 2020 bull phase, CryptoQuant CEO says </a>
<h2 class="wp-block-heading" id="public-companies-rush-to-embrace-bitcoin-as-treasury-asset">Public companies rush to embrace Bitcoin as treasury asset</h2>
The move aligns with a growing trend among public companies incorporating Bitcoin into their financial strategies. Artificial intelligence firm Genius Group recently also <a href="https://crypto.news/ai-firm-genius-group-boosts-bitcoin-treasury-with-14m-purchase/" target="_blank" rel="noopener noreferrer nofollow">announced</a> $4 million in BTC purchases, raising its holdings to 153 BTC as part of its “Bitcoin-first” strategy to allocate 90% or more of its reserves to the cryptocurrency.
Other companies, including MicroStrategy and Nasdaq-listed Acurx, have also <a href="https://crypto.news/nasdaq-listed-antibiotics-developer-acurx-to-put-1m-in-bitcoin-on-balance-sheet/" target="_blank" rel="noopener noreferrer nofollow">expanded</a> their Bitcoin holdings to capitalize on its role as a hedge against inflation and a store of value supporting technological innovation.
Read more: <a rel="noopener noreferrer nofollow" href="https://crypto.news/public-fitness-equipment-maker-interactive-strength-shares-rise-11-on-bitcoin-treasury-strategy/"> Public fitness equipment maker Interactive Strength shares rise 11% on Bitcoin treasury strategy </a>

Anixa Biosciences expands treasury strategy with Bitcoin

Table of Contents

crypto.news

Other articles published on Nov 22, 2024

Crypto Lists Reaches 150 New BTC Casino Reviews

ETH Price Rise: Whale Moves & ICO Fund Distribution in Focus

AI Predicts When Dogecoin Could Hit $1

SHIB Price Dips 3.4% Amid Possible Reveal of Shiba Inu Creator’s Wallet

Crypto Giants Head to the White House: Trump’s Advisory Council Draws Attention

U.S. Senator Proposes Selling Gold to Build Bitcoin Reserves

Join our free newsletter for daily crypto updates!